BioUtah News
-
Pfizer to Acquire Arena Pharmaceuticals
Pfizer and Arena Pharmaceutical on Dec. 13 announced that the companies have entered into an agreement under which…
-
IONIQ Sciences recognized as “Most Innovative Non-Invasive Lung Cancer Testing Solution” and “Best Medical Technology Company 2021″
IONIQ Sciences, Inc. announced it has been awarded “Most Innovative Non-Invasive Lung Cancer Testing Solution” and “Best Medical Technology…
-
Clene Nanomedicine’s Patent Portfolio Grows to More Than 150 Issued Worldwide, including Two Key Patents Now Validated Across Europe
Powerful combination of key patents comes as the Company looks ahead to topline results from a Phase 3…
-
Clene Nanomedicine to Present RESCUE-ALS Phase 2 Data in Late-Breaking Session at 32nd International Symposium on ALS/MND
Clene presented data from the RESCUE-ALS Phase 2 study of CNM-Au8®, a catalytically active gold nanocrystal suspension, for…
-
Pfizer to Acquire Arena Pharmaceuticals
Arena Pharmaceuticals, Inc. and Pfizer Inc. have entered into a definitive agreement under which Pfizer will acquire Arena.
-
IONIQ’s breast cancer feasibility results published by IEEE
Salt Lake City, November 30, 2021 – In collaboration with two of our Scientific Advisors, IONIQ Sciences, Inc.…
-
Recursion loops in Roche, Genentech for multibillion-dollar AI drug discovery deal
The artificial-intelligence-powered drug designer Recursion signed on to a wide-ranging collaboration with Roche and its Genentech division.
-
ARUP Laboratories Earns Fourth Consecutive Utah Business Best Companies To Work For Award
For the fourth consecutive year, Utah Business magazine has honored ARUP Laboratories with its Best Companies to Work…
-
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022
Renalytix reported financial results for the quarter ended September 30, 2021.
-
Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Patients Using Machine Learning and High Content Screening Methods at Scale to Map Complex Biology
The deal, worth several billion dollars, is a future-looking model of technology-enabled target and drug discovery
-
Recursion and Bayer Expand Fibrosis Collaboration to Include Inferential Search Capabilities
Use of latest Recursion inference technologies to expand exploration of fibrosis and may extend the collaboration to more…
-
Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for ABC Multiplex Test
Co-Diagnostics announced that CoSara Diagnostics Pvt Ltd has received clearance by the Central Drugs Standard Control Organization (CDSCO)…
-
Foldax Receives Approval for Clinical Trial of TRIA Biopolymer Surgical Aortic Heart Valve in India
Foldax announces that the Drugs Controller General of India (DCGI) has approved initiation of a clinical trial of…
-
HSS and Rothman Institute/Jefferson University Hospital to Participate in Clinical Trial for Elute’s Antibiotic Loaded Bone Void Filler
Collaboration Expands Clinical Sites for Trial
-
NIH AWARDS SINTX TECHNOLOGIES PHASE 1 GRANT FOR SN-PEEK 3D PRINTED SPINAL IMPLANTS
NATIONAL INSTITUTE OF HEALTH AWARDS SINTX TECHNOLOGIES PHASE 1 GRANT FOR SN-PEEK 3D PRINTED SPINAL IMPLANTS
-
Fluidx Medical Technology Announces Series A Led by Multinational Strategic Investor
Novel Oncology Embolic Device financing supports prospective, clinical trials and market entry
-
IONIQ Sciences proudly announces that Mrs. Jan Poulsen is a Lung Cancer Hero
IONIQ Sciences Proudly Announces that Mrs. Jan Poulsen is a Lung Cancer Hero
-
Co-Diagnostics, Inc. Reports that Suite of COVID-19 Diagnostics Not Affected by Heavily Mutated Omicron Variant
None of the mutations in the Omicron variant interfere with any of the Company’s COVID-19 PCR diagnostic assays
-
CAO Group Launches The World’s First In-Office And Take Home Teeth Whitening Strip System
The CAO Group, Inc. has launched the world’s first in-office and take-home teeth whitening strip system for dental…
-
IONIQ Sciences Announces MedTech Breakthrough Award for “Oncology Innovation of the Year 2021”
IONIQ Sciences Announces MedTech Breakthrough Award for “Oncology Innovation of the Year 2021”
-
Bluewind Medical™ Ltd. Completes OASIS Study Patient Enrollment
Bluewind Medical announced the successful completion of patient enrollment in the OASIS pivotal clinical study that will be…
-
Recap of the Virtual 2021 BioHive Renalytix Summit
BioUtah and BioHive on Nov. 12 presented with great fanfare the Renalytix BioHive Summit – the 12th annual…
-
Hatch Warns of Dangers to the Generic Drug Market
Statement from Senator Orrin G. Hatch: Drug Pricing Provisions in Infrastructure Bill Could Undermine Hatch-Waxman
-
NuView Life Sciences Creates Subsidiary for Latin American Market
Introducing a New Approach to Diagnose and Treat Cancer. NuView Life Sciences, Inc established NuView LATAM in Mexico…
-
FDA clears the nView s1 imaging system with integrated navigation
nView announces the 510(k) clearance of the nView s1 with navigation option by the FDA along with AI-enabled…
-
Co-Diagnostics Reports Continued Strength in Third Quarter 2021 Financial Results
Solid quarterly results highlighted by record revenue of $30.1 million, pre-tax income of $13.6 million and fully diluted…
-
State Legislature Passes Statute regulating mandatory vaccination policies in the workplace.
The Utah legislature convened in special session this week regarding the issuance of an OSHA Emergency Temporary Standard…
-
AdvaMed Statement on Administration’s COVID-19 Testing Policy for Employers
AdvaMed released a statement from AdvaMedDx Executive Director Susan Van Meter on the testing policy regulation recently proposed…
-
PolarityTE Reports Third Quarter Financial Results and Provides Business Update
PolarityTE, Inc. recently provided a business update and reported financial results for the three and nine-month periods ended…
-
Renalytix Convenes Expert Panel at VA Healthcare Summit
Leading clinicians discuss enabling long-term kidney health in Veterans with type 2 diabetes and early-stage chronic kidney disease
-
St. Joseph’s Health and Renalytix Partner to Advance Value-Based Kidney Health in New York
Partnership expands doctor and patient access to advanced prognosis and coordinated care management of early-stage diabetic kidney disease
-
Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1 Study of DSP-0390 in Patients with Recurrent High-Grade Glioma
Sumitomo Dainippon Pharma Oncology (SDP Oncology), which has research facilities in Lehi, Utah, recently announced that the first…
-
Co-Diagnostics, Inc. Logix Smart™ COVID-19 2-Gene Test Approved for Use in the United Kingdom
Company’s validated test available in the UK following implementation of UKHSA CTDA Regulations
-
New report shows more than 260 medicines in development to fight neurodegenerative diseases
PhRMA released a new report detailing the more than 260 medicines in development for 29 neurodegenerative diseases
-
Clene Nanomedicine Announces Top-Line Results from Phase 2 RESCUE-ALS Clinical Trial
Clene recently announced top-line data from RESCUE-ALS, a Phase 2 clinical trial evaluating CNM-Au8 as a disease modifying…
-
Wilson Sonsini to open Salt Lake City office with trio of lawyers
Wilson Sonsini Goodrich & Rosati to open an office in Salt Lake City, becoming the latest major U.S.…
-
Myriad Genetics Reports Third Quarter 2021 Results, Continues Strong Execution of Strategic Growth & Transformation Plans
Myriad Genetics announced financial results for its third quarter ended September 30, 2021 and provided an update on…
-
FDA Clears 12 New XO Cross Microcatheters
12 new hydrophilic-coated micro and support catheters cleared by FDA for broad use in the peripheral vasculature.
-
St. George could become Utah’s next tech hub
Utah has now become a VC darling with a maturing ecosystem complete with angels, seed-stage, growth stage, and…
-
Innovative Embolic Device Shows Promise for Interventional Oncology Drug Delivery
Fluidx Medical’s GPX Embolic Device Releases Initial Results for Oncology Drug Delivery
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
